2014
DOI: 10.7314/apjcp.2014.15.11.4443
|View full text |Cite
|
Sign up to set email alerts
|

An Updated Meta-analysis on the Association of X-Ray Repair Cross Complementing Group 1 Codon 399 Polymorphism with Hepatocellular Carcinoma Risk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 34 publications
0
4
0
Order By: Relevance
“…Genetic variations in different individuals may alter the function of cytokine proteins, influencing the risk (Cheng et al, 2013;Liu et al, 2014;Wang et al, 2014;Zhang et al, 2014) and clinical outcomes of HCC (Pan et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…Genetic variations in different individuals may alter the function of cytokine proteins, influencing the risk (Cheng et al, 2013;Liu et al, 2014;Wang et al, 2014;Zhang et al, 2014) and clinical outcomes of HCC (Pan et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…Since this is preliminary report, our study is affected by the following limitations: (a) although there are 3 common single-nucleotide polymorphism (SNP) sites in the XRCC1 gene, and haplotype analyses could increase the power of the statistical analysis, a careful review of the literature leads us to analyze only the XRCC1 Arg399Gln polymorphism (14,(45)(46)(47)(48); (b) despite the fact that our analysis has shown no significant correlation between the XRCC1 Arg399Gln polymorphism and susceptibility to HCC in HCV-positive patients, as confirmed in previous studies (14), further analysis are needed to evaluate if HCV-positive status could be a significant variable in HCC patients…”
Section: Discussionmentioning
confidence: 99%
“…Current XRCC1 polymorphism studies mainly focus on 3 nonsynonymous mutant SNPs, namely Arg194Trp (rs1799782), Arg280His (rs25489), Arg399Gln (rs25487). The relationship between XRCC1 polymorphism and susceptibility to malignant tumors (such as nasopharyngeal cancer, breast cancer, lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, prostate cancer, glioma, etc) has been reported many times [9–15] . Among the 3 non-synonymous mutated SNPs, Arg399Gln, and Arg194Trp were most correlated with cervical cancer susceptibility, but the conclusions were inconsistent.…”
Section: Introductionmentioning
confidence: 99%
“…The relationship between XRCC1 polymorphism and susceptibility to malignant tumors (such as nasopharyngeal cancer, breast cancer, lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, prostate cancer, glioma, etc) has been reported many times. [9][10][11][12][13][14][15] Among the 3 nonsynonymous mutated SNPs, Arg399Gln, and Arg194Trp were most correlated with cervical cancer susceptibility, but the conclusions were inconsistent. Therefore, this study used metaanalysis method to explore the relationship between XRCC1 Arg399Gln, Arg194Trp, Arg280His and susceptibility to 3 common female reproductive system tumors.…”
Section: Introductionmentioning
confidence: 99%